Over the past 12 months, 0 insiders at Protara Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on TARA: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 14, 25 | Richard S LevyDirector | BUY | 20.0K | $3.19 | $64K |
| Mar 26, 25 | Jacqueline ZummoChf Scientific Operations Off | SELL | 21.2K | $4.53 | $96K |
| Sep 12, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 119.8K | $1.71 | $205K |
| Sep 11, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 31.0K | $1.71 | $53K |
| Sep 10, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 24.0K | $1.77 | $42K |
| Sep 9, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 34.6K | $1.89 | $65K |
| Jul 16, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 7.9K | $2.44 | $19K |
| Jul 11, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 33.0K | $2.40 | $79K |
| Jul 10, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 13.1K | $2.31 | $30K |
| Jul 9, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 6.0K | $2.21 | $13K |
| Jul 1, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 5.8K | $2.12 | $12K |
| Jun 28, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 13.0K | $2.07 | $27K |
| Jun 27, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 34.1K | $2.26 | $77K |
| Jun 25, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 6.5K | $2.26 | $15K |
| May 31, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 5.8K | $2.90 | $17K |
| May 30, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 9.2K | $2.94 | $27K |
| May 22, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 9.3K | $3.02 | $28K |
| May 21, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 31.2K | $3.06 | $95K |
| May 17, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 47.3K | $3.33 | $157K |
| May 10, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 151.7K | $3.11 | $472K |
| May 9, 24 | Opaleye Management Inc.TenPercentOwner | SELL | 30.6K | $3.09 | $95K |
| Dec 30, 22 | Opaleye Management Inc.TenPercentOwner | SELL | 13.2K | $2.71 | $36K |
| Sep 15, 22 | Opaleye Management Inc.TenPercentOwner | BUY | 5.0K | $3.80 | $19K |
| Sep 14, 22 | Opaleye Management Inc.TenPercentOwner | BUY | 14.1K | $3.98 | $56K |
| Aug 11, 22 | Jesse SheffermanCEO and President | BUY | 9.1K | $3.84 | $35K |
| Jun 30, 22 | Luke M BesharDirector | BUY | 10.0K | $3.10 | $31K |
| Apr 8, 22 | Opaleye Management Inc.TenPercentOwner | BUY | 5.3K | $4.80 | $26K |
| Apr 7, 22 | Opaleye Management Inc.TenPercentOwner | BUY | 1.3K | $4.74 | $6K |
| Mar 14, 22 | Luke M BesharDirector | BUY | 10.0K | $4.25 | $43K |
| Mar 10, 22 | Luke M BesharDirector | BUY | 10.0K | $4.46 | $45K |
| Jan 28, 22 | Opaleye Management Inc.TenPercentOwner | BUY | 20.0K | $4.96 | $99K |
| Dec 29, 21 | Opaleye Management Inc.TenPercentOwner | BUY | 4.5K | $6.98 | $31K |
| Dec 28, 21 | Opaleye Management Inc.TenPercentOwner | BUY | 5.5K | $6.36 | $35K |
| Dec 27, 21 | Opaleye Management Inc.TenPercentOwner | BUY | 31.7K | $6.53 | $207K |
| Dec 23, 21 | Opaleye Management Inc.TenPercentOwner | BUY | 800 | $6.60 | $5K |
| Dec 20, 21 | Opaleye Management Inc.TenPercentOwner | BUY | 703 | $6.49 | $5K |
| Dec 17, 21 | Opaleye Management Inc.TenPercentOwner | BUY | 2.3K | $6.60 | $15K |
| Dec 16, 21 | Opaleye Management Inc.TenPercentOwner | BUY | 6.5K | $6.41 | $42K |
| Nov 18, 21 | Opaleye Management Inc.TenPercentOwner | BUY | 14.2K | $6.98 | $99K |
| Nov 17, 21 | Opaleye Management Inc.TenPercentOwner | BUY | 8.0K | $6.98 | $56K |
| Nov 4, 21 | Opaleye Management Inc.TenPercentOwner | BUY | 6.0K | $6.50 | $39K |
Over the past 12 months, insiders at Protara Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on TARA, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market TARA insider purchase in our data was $207K by Opaleye Management Inc., TenPercentOwner, filed on Dec 27, 21.
0 different insiders at Protara Therapeutics, Inc. filed open-market SEC Form 4 transactions on TARA over the last 12 months.
InsiderTape plots every TARA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Protara Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →